Write Down This Ticker Today…
August 31, 2026 Bonus Content: New EVs Stall. Used EVs Surge. Same Buyer. A note...
JPMorgan Just Blinked. Goldman Is Holding the Other Side.
With hike odds near 60% and the 10-year around 4.75%, JPMorgan went cautious Monday. Goldman says that caution is misplaced.
New EVs Stall. Used EVs Surge. Same Buyer.
The tax credit cliff didn’t kill EV demand. It redirected it, and the split tells traders where the real market…
Myqorzo’s Balance Sheet Meets Its Biggest Catalyst
With $1.7B in cash and a Q4 sNDA plan, Cytokinetics just validated a major untreated corner of HCM.
The Grid Can’t Keep Up With AI
PJM’s third straight auction at the price cap is locking in a decade-long tailwind for owners of dispatchable power.
Nvidia Moved the Market. Most Stocks Didn’t.
August 30, 2026 One stock added $442 billion in a single session. Here’s what that...
Google’s Price War Hits Snowflake’s Meter
Wednesday’s Q2 report tests whether consumption-billed AI workloads can expand faster than Google cuts the cost of running them.
The Balance Sheet Case Against Small Caps
Warsh's Jackson Hole warning has institutions screening the Russell 2000 for interest coverage, not valuation.
When the Brake Fails: Trading Into a Data Week
August 29, 2026 A tiny benchmark revision dulls the labor-market bear case six days before...
ROIV Has Its First Approval. Now Comes the Harder Part.
Lisraya wins dermatomyositis, but a boxed warning, a larger patient pool than advertised, and Phase 3 readouts define what the…